BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.26% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IRD
4901
Opus Genetics
IRD
$306M
| $136K | ﹤0.01% |
71,169
+36,903
| +108% | +$83.9K |
|
4902
DiaMedica Therapeutics
DMAC
$342M
| $135K | ﹤0.01% |
66,717
+10,278
| +18% | +$24K |
|
4903
Rocky Mountain Chocolate Factory
RMCF
$7.93M
| $135K | ﹤0.01% |
19,547
-1,227
| -6% | -$8.22K |
|
|
FORTY
4904
Formula Systems
FORTY
$1.66B
| $134K | ﹤0.01% |
1,442
-514
| -26% | -$48.5K |
|
|
CEMI
4905
DELISTED
Chembio diagnostics, Inc.
CEMI
| $134K | ﹤0.01% |
206,716
-75,822
| -27% | -$50.4K |
|
|
DFTX
4906
Definium Therapeutics
DFTX
$5.78B
| $133K | ﹤0.01% |
13,873
-1,081,741
| -99% | -$13.7M |
|
4907
Corvex Inc
MOVE
$299M
| $133K | ﹤0.01% |
503
+253
| +101% | +$67K |
|
4908
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.62B
| $133K | ﹤0.01% |
3,334
-79
| -2% | -$3.4K |
|
|
HYPD
4909
Hyperion DeFi Inc
HYPD
$40M
| $132K | ﹤0.01% |
849
+98
| +13% | +$17.9K |
|
4910
Home Federal Bancorp
HFBL
$71.3M
| $132K | ﹤0.01% |
6,728
-579
| -8% | -$11.6K |
|
4911
Natural Alternatives International
NAII
$14.4M
| $132K | ﹤0.01% |
12,669
-1,180
| -9% | -$12K |
|
|
CEPU
4912
Central Puerto
CEPU
$2.29B
| $130K | ﹤0.01% |
42,296
-6,843
| -14% | -$24.9K |
|
4913
iShares Morningstar Multi-Asset Income ETF
IYLD
$125M
| $130K | ﹤0.01% |
6,549
| – | – |
|
4914
Network-1 Technologies
NTIP
$37M
| $130K | ﹤0.01% |
53,960
+7,725
| +17% | +$18.9K |
|
4915
Ternium
TX
$9.67B
| $130K | ﹤0.01% |
3,600
-345
| -9% | -$14.7K |
|
4916
Vanguard High Dividend Yield ETF
VYM
$80.9B
| $130K | ﹤0.01% |
1,276
+131
| +11% | +$14.2K |
|
|
LOMA
4917
Loma Negra
LOMA
$1.34B
| $129K | ﹤0.01% |
25,423
-3,912
| -13% | -$22.3K |
|
4918
Lantern Pharma
LTRN
$33.6M
| $129K | ﹤0.01% |
22,762
-312
| -1% | -$1.86K |
|
|
GVP
4919
DELISTED
GSE Systems, Inc.
GVP
| $129K | ﹤0.01% |
10,294
+4,693
| +84% | +$70.6K |
|
4920
BK Technologies
BKTI
$300M
| $127K | ﹤0.01% |
9,632
-1,094
| -10% | -$13.3K |
|
4921
Envela
ELA
$563M
| $127K | ﹤0.01% |
17,829
-3,065
| -15% | -$16.6K |
|
|
NVNO
4922
enVVeno Medical
NVNO
$7.08M
| $127K | ﹤0.01% |
955
-143
| -13% | -$22.2K |
|
4923
ReWalk Robotics
LFWD
$20.3M
| $127K | ﹤0.01% |
1,618
+246
| +18% | +$20.9K |
|
4924
Immunome
IMNM
$2.58B
| $126K | ﹤0.01% |
39,211
-357
| -0.9% | -$1.3K |
|
4925
Cyngn
CYN
$15.3M
| $125K | ﹤0.01% |
8
+7
| +700% | +$203K |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,355 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.